Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Update

17 May 2017 07:00

RNS Number : 3471F
Tarsus Group PLC
17 May 2017
 

17 May 2017

 

Tarsus Group plc

 

Trading Update

 

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, is today providing a trading update on its current financial year to date.

 

Trading since the publication of the Group's Annual Results on 1 March 2017 has been in-line with Board expectations, with good performances to date across the Group's portfolio.

 

Following the Group's strong performance in 2016, our "Quickening the Pace" strategy continues to gain momentum. Our recent major acquisitions, Connect and Hometex, are integrating well and we are seeing more opportunities for future organic growth than we anticipated at the time of the acquisitions. In line with our strategy, we continue to scale our businesses in the US and China and we expect these regions to add significantly to our organic growth over the medium term. Event replications continue to gain momentum and we are moving into the next stage of scaling them.

Overall, forward bookings for the full year are tracking 9% ahead on a like-for-like basis.

 

Americas

The US portfolio has seen a good performance across the business so far this year. The Connect events have performed well and we are pleased with the opportunities to develop the existing events and launch new ones. Our Medical portfolio continues its pattern of growth, as seen in 2016.

 

In Mexico, trading continues positively with two replications held there (GESS Mexico and Airport Solutions) in the period performing well.

 

EMEA

In Dubai, our leading education show GESS produced another solid performance. In Turkey, given the geo-political environment the market remains unsettled. Exhibitions held so far in Turkey have performed in line with our cautious budgeting with recent events showing modest like-for-like revenue growth.

 

Asia

In Asia the Group's Chinese portfolio, which is heavily first half weighted, has performed very well. The first edition held under the Group's ownership of the Spring Hometex event performed strongly, as expected. This show has a waiting list of exhibitors and will benefit in due course from the additional exhibition space being added in Shenzhen in 2019.

 

Douglas Emslie, Tarsus Group Managing Director, said:

 

"Our strong focus on both the experience and return on investment that we provide to our customers continues to drive scale and momentum in our business. We have seen encouraging performances across the portfolio so far this year and our forward bookings, including those of our two largest biennial events, Labelexpo Europe and the Dubai Airshow, are strong.

 

"We are excited about the organic growth prospects of the business and we remain confident about the outlook for 2017."

 

The Group plans to announce its Interim Results for the six months ended 30 June 2017 on 26 July 2017.

 

For further information:

 

Tarsus Group plc:

 

 

Douglas Emslie, Group Managing Director

 

+44 (0) 20 8846 2700

Dan O'Brien, Group Finance Director

 

Neville Harris, Investor Relations

 

+44 (0)7909 976044 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUAAAUPMGQQ
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBlock Listing Six Monthly Return
9th May 20187:00 amRNSBoard Changes
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.